#Software for DSCSA

[drugzonepharmaceuticalsinc]

What is EPCIS 2.0?

The world of pharmacy distribution is constantly evolving, driven by technological advancements that promise to enhance efficiency and traceability. One such groundbreaking innovation is EPCIS 2.0. But what exactly is EPCIS 2.0, and how can it benefit pharmacy distributors? In this blog post, we'll explore the intricacies of EPCIS 2.0, its applications, and why it's pivotal for the pharmaceutical industry.

Understanding EPCIS 2.0

EPCIS, or Electronic Product Code Information Services, is a global standard for sharing supply chain visibility data. The updated EPCIS 2.0 enhances data sharing and interoperability, allowing businesses to track product movements and statuses with detailed information. This is especially valuable for pharmacy distributors to ensure accurate tracking from manufacturer to patient.

Why EPCIS 2.0 Matters

EPCIS 2.0 boosts supply chain transparency and efficiency in the pharmaceutical industry. It offers real-time tracking to reduce counterfeit risks and automates data collection to streamline processes, resulting in fewer errors and faster deliveries.

Improved Data Sharing

EPCIS 2.0 enables seamless data sharing between stakeholders, crucial for maintaining supply chain integrity in the pharmaceutical sector. It offers traceability for defective medication, aiding compliance with regulations. A DSCSA study found over 90% of pharmacy distributors experienced better compliance and reduced administrative burdens after adopting EPCIS standards.

Interoperability with Existing Systems

EPCIS 2.0 is designed to integrate smoothly with existing enterprise systems. For pharmacy distributors, this means they can leverage their current infrastructure while reaping the benefits of enhanced data visibility. Whether it's an ERP system, warehouse management software, or transportation management system, EPCIS 2.0 ensures compatibility and easy implementation.

Real-World Applications

Several leading pharmacy distributors have already begun to implement EPCIS 2.0, showcasing its real-world benefits. For example, Drugzone, a prominent name in the pharmaceutical industry, reported a 25% increase in operational efficiency and a 15% reduction in shipment errors after integrating EPCIS 2.0 into their processes.

Boosting Competitive Advantage

In a competitive market, staying ahead often means adopting the latest technologies. EPCIS 2.0 not only improves operational efficiency but also provides a competitive edge. Pharmacy distributors that utilize this standard can offer better service reliability, which can be a significant differentiator in the market.

Conclusion

EPCIS 2.0 is a crucial advancement in pharmacy distribution, boosting transparency, efficiency, and compliance. For pharmacy distributors aiming to stay competitive, adopting EPCIS 2.0 is essential. Learn more about its benefits and start your journey at Drugzone.

[interwork2018-blog]

THE MOST INNOVATIVE THINGS ARE HAPPENING WITH BLOCKCHAIN FOR DSCSA DRUG SERIALIZATION

The Dynamic Duo: Blockchain for DSCSA Drug Serialization

The US Congress has enacted the drug supply chain security act 2013. Since then, technology businesses have aggressively explored all possible permutations and combinations of technology. The objective has been to build solutions to build a highly reliable system that closely works to help companies seamlessly scale without worrying about DSCSA serialization compliance.

The motive behind Blockchain for DSCSA Drug Serialization is to counter increasing time-material costs of supply chain operations, restricted supplies due to the productivity of employees, and excessively increase turnaround time in fulfilling requirements at the bulk level in the pharmaceutical supply chain. Ultimately, a sustainable Solution of Blockchain for DSCSA Drug Serialization has turned out to be the most beneficial one. Let us see how.

Innovations with Blockchain for DSCSA Drugs Serialization

While there are some changes to the Blockchain for Drug Serialization for DSCSA, the most primitive ones are:

A Single Solution, Double Purpose

One of the significant problems is that it is not able to seamlessly integrate with existing technology resources. Blockchain is capable of offering an all-round supply chain management solution instead of just focusing on Blockchain for DSCSA Serialization requirements. If the adoption of Blockchain for DSCSA Drug Serialization is Strategic, it offers the completeness of solutions for long-term stellar growth.

Multi-stakeholder operations

Other solutions just offer convincing answers to one, two, or a maximum of three stakeholders who are the primary supply chain partners. But according to US FDA, DSCSA serialization requires a top-notch level of communication in a highly secured environment for efficiently curbing drug counterfeiting. The dire need for enhancing drug track and trace capability is promoting Blockchain for DSCSA Drug Serialization.

Best use of Decentralized Database

A Blockchain for DSCSA Serialization offers a decentralized database accessible to all supply chain partners enhancing Blockchain-Based Drug Track and Trace. It also comes with an added innovation which lets regulatory bodies and US FDA regulators to conveniently fetch the transacting drug lot database from any timeline during the passage of the lots between any two supply chain partners.

Counterfeit Detection System

The newest innovations in the blockchain for DSCSA drug serialization make blockchain-based drug track and trace solutions highly capable of implementing improve counterfeit detection systems. Any discrepancies or a non-uniformity is in redirected transactions from different stakeholders down the line of all Pharma supply chain critically flagged for scrutiny by supply chain partners and regulatory bodies.

Real-Time Transaction and Notification System

Blockchain-Based Drug Track and Trace has greatly innovated to make life easier for major Pharma supply chain partners in the US market. They are doing so by helping suppliers and partners receive notifications of all transactions anywhere in the supply chain, which they can acknowledge after verification with all serialization relevant data. These notifications capable of driving positive attention of all regulatory bodies and supply chain partners to leave no scope for uncontrolled introduction of counterfeit into the mainstream supply chain.

Seamless Database Migration & Adoption

Innovative use of Blockchain for DSCSA Drug Serialization opens up the unlimited scope of migration and adoption of a new database as per DSCSA serialization standards. According to the DSCSA, all suppliers and partners are expected to maintain a highly active database, including all details like:

What to Expect From the Future?

Supply chain components like third party verification

The localization of a database copy

Integration scenarios like ERP-SCM

Data interoperability

AI-IoT based systems for warehousing, counterfeit, SCM operations

Conclusion

As the essential deadline for DSCSA full completion of serialization infrastructure set up nears, Blockchain-Based Drug Track and Trace will become an inevitable part of US-based pharmaceutical supply chain management business. Businesses that will pay required attention to proper efforts with Blockchain for DSCSA Drug Serialization with the right blockchain-based drug track and track solution will reach excellent benefits with an unbeatable advantage over others. In the future, USFDA takes strict measures and issue sanctions for tightening screws on drug counterfeiting in the upcoming years.

[californiadesrep]

These online training courses are approved by the California State Board of Pharmacy. Sign-up for a course now to earn a training affidavit for your California Designated Representative license application:

California Designated Representative Wholesalers

California Designated Representative 3PL

California Designated Representative Reverse Distributors

[infinitrak]

Achieving DSCSA Compliance and Patient Safety with Our Comprehensive Solutions

DSCSA compliance is a critical issue for businesses in the pharmaceutical industry. The Drug Supply Chain Security Act (DSCSA) is a federal law that aims to improve the security and traceability of pharmaceutical products as they move through the supply chain. Compliance with the DSCSA is crucial for ensuring that only legitimate and safe products reach patients.

Our company specializes in providing solutions for DSCSA compliance. We understand the complexities of the pharmaceutical supply chain and have the expertise to help your business comply with the DSCSA requirements. Our solutions include software for tracking and tracing products, as well as training and consulting services to ensure that your business is fully compliant.

Our software is user-friendly and can be easily integrated into your existing systems, making it easy to keep track of your products and ensure compliance. Our training and consulting services will help your employees understand the requirements of the DSCSA and how to implement them.

Don't risk non-compliance with the DSCSA. Contact us today to learn how we can help your business stay compliant and protect the safety of your patients.

Need to Know more about DSCSA Compliance and Patient Safety, visit our website.

[rohit890]

Artwork Management Software Market Business Opportunities, Future Scope And Top Keyplayers 2031

Market Overview

The global artwork management software market was valued at US$ 5.1 billion in 2021 and it is anticipated to grow up to US$ 10.9 billion by 2031, at a CAGR of 7.8% during the forecast period.

Artwork management is the practice of simplifying approval cycles, reducing manual processes, and increasing overall efficiency. Artwork management software streamlines the process to save users time and money, help the user stay organized, and keep branding consistent and accurate. Artwork management software helps to bring the whole team to one place, proof artworks faster, and manage assets in one place, meaning faster approvals, fewer iterations, and more productivity. Further, cosmetic, chemical, food and beverage, life sciences, pharmaceuticals, chemicals, paints, manufacturing, packaging, design agencies, and marketing companies are adopting this software.

View Detailed Report Description: https://www.globalinsightservices.com/reports/artwork-management-software-market/

Market Dynamics

The artwork management software market growth is attributed to the expansion of pharma and life science businesses. With the increasing demand for medicines and other life science elements worldwide, the need for artwork management tools is also increasing. Throughout the pharmaceutical sector, packaging & labeling are highly recognized as a mission-critical process, which assists the organization in framing strategic goals for attracting more customers. And frequent label changes and implementation of new rules & regulations is helping in artwork management software market growth, as artwork management system helps reduce discrepancies in processes, lower human errors, and improve label quality & business agility. Moreover, the medical device firms have to comply with regulatory requirements such as the European Union’s MDR systems and Falsified Medicines Directive (FMD), Drug Supply Chain Security Act (DSCSA), and Food and Drug Administration’s Unique Device Identification (UDI) to maintain the smooth operations of pharmaceutical and life sciences sectors. Therefore, the manufacturers are reviewing medical device packaging and barcode labeling processes to comply with the emerging regulatory requirements, and for that, artwork management software is necessary.

In this day and age, cyber security should be a top priority in companies of all types and sizes. The number of threats and their sophistication is increasing by the day. Data has become the lifeblood of most organizations and the major driver of day-to-day operations and top-level decision-making. Security breaches that lead to loss of data can result in a catastrophe. Not taking cyber security seriously can lead to irreparable reputational damage, fines & issues with licensing in the case of regulated businesses, adverse media coverage, increased anxiety & stress levels in the workforce, business interruption, and breach of privacy & financial losses. And some of the artwork management software are unable to counter cyber-attacks. Thus, security concerns due to the lack of cybersecurity measures are acting as a restraining factor for the global artwork management software market.

Get Free Sample Copy of This Report: https://www.globalinsightservices.com/request-sample/GIS10400

The key players studied in the global artwork management software market are Discus IT Pvt Ltd (India), Esko (Belgium), Freyr (US), GreatFour Systems (US), Kallik Ltd. (UK), Karomi Inc (ManageArtworks) [US], Lascom (Aptean) [US], Loftware, Inc. (US), Perigord Asset Holdings Limited (Ireland), and Twona (The Netherlands).

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[pharmasecureus]

US DSCSA serialisation service providers consider creating robust, secure, and scalable hardware and software solutions to increase supply chains and defend brands against reproduction while deriving benefit from involving cases and increasing health outcomes.

URL: -

For More Detail Visit:-

https://www.pharmasecure.com

[arirmspos]

6 Essential features of Pharmacy management system needed in 2021

1. Reports & Analytics

The pharmacy management system generates reports to check the wholesales’ performance. Reporting & analytics prepare for the pre-requirement of drugs. It also automatically manages the inventory. The feature calculates the number of needed medications. The reporting system enhances sales and ROI (Return of Investment). Moreover, it provides a full report of the pharma business activities.

2. Centralized Database

Data is a crucial element of the pharma business. Furthermore, a centralized database holds the patient’s data at a centralized location. The pharmacy management system provides easy data retrieval. It also manages transactional records. The system eliminates data loss. Additionally, it stores data about drugs and medications. Thus, the set-up provides information for drug availability.

3. Feature of Restore & Backup System of pharmacy management system

What happens when the data is lost suddenly? The business operations may stop abruptly. Data such as patient records and inventory is always at risk. A restore and backup system avoids unnecessary data loss. This system eliminates technical errors while retrieving data quickly.

Read More : Click Here

4. Customer Management System

Customers are at the core of any system designed for businesses. Pharmacy management systems must have an automated solution to manage patients. CMS also keeps a record of the patient’s data. Furthermore, it is a dynamic solution that adds new customers. Well-organized CMS holds customer responses and feedback. Hence, Pharmacists develop business strategies to manage customer requirements.

5. Integration with third-party software

Integration with third-party software manages back-office operations. Enables efficient data flows for prescription and inventory data. US pharmacists integrate with prescription drug monitoring programs. EHR/EMR integration to access patient records. E-prescribing software integration to control medical receipts.

6. Regulatory & Compliance of pharmacy management system

The compliance regulations cover each dimension of pharma practice. POS solutions address compliance for drug ordering and e-prescription.

US and EU regulators use advanced technologies to standardize the dispense of medication. The federal law Drug Supply Chain Security Act (DSCSA) protects against the dispensing of fake prescribed medications. In the EU, various drug suppliers ensure drug authenticity using a ‘point-of-dispense’ verification system. NAPRA is an association that governs pharmacies across Canada.

About Ari

Ari pos, a retail management system, is preferred by many retailers around the globe. Ari has many features and functionalities that benefit a retailer in day-to-day operations. There is a possibility of creating rewards programs and promotional strategies in Ari. You can also design sales promotion strategies and manage them through Ari.

[meta-pharma]

How to manage your Inventory between your Pharmaceutical Distribution and 3PL

Moving with a 3PL (third-party logistics) provider model is common practice as businesses seek to exploit value throughout the supply chain. Instead of handling warehouse space, they use to pay a 3PL to handle the pick, pack, receipt, and shipping of product on their behalf. By doing this, the manufacturer ships products directly to the 3PL where orders are then fulfilled on behalf of the Wholesaler or Pharmaceutical Distributors.

This technique is basically for SMEs who do not wish to incur the costs associated with managing and staffing warehouse space, and for businesses that sell across the country and can benefit from multiple locations strategically placed. Before you decide on a 3PL partner, you need to consider all of the features of pharmaceutical ERP software. Below we explore how a Pharmaceutical ERP plays an important role and automates your business processes.

Pharmaceutical products require specialized procedures for their receipt, storage, handling, and distribution to their final destination.  Meta-Pharma, an ERP Solution for Pharmaceuticals Industry combines years of experience with a technologically advanced infrastructure for a sense of confidence and commitment that clients rely on and appreciate for the needs of pharmaceutical warehouse and distribution.

Meta-Pharma and Automated Processes

MetaPharma is an ERP Solution for Pharmaceuticals Industry built on Microsoft Dynamics 365 Business Central. It includes robust accounting and inventory management features and advanced functionality. Which work for traceability, lot tracking, regulatory compliance with the DEA, FDA, and DSCSA, and warehouse management. These features work together to automate processes and grow your business, increase transparency, and aid in regulatory compliance.

Meta-Pharma is an ERP Solution for Pharmaceuticals that can integrate with the systems used by your 3PL partners. Just like you need a solution to manage your daily business operations. Meta-Pharma with 3PL provides more chances for automation so that it can easily eliminate manual processes and the risk of human error.

Basically, it can be go through EDI, this integration allows your system to connect directly to the system of each of your 3PL partners. It means that instead of manually sending and receiving information and then manually updating your software, the systems can directly exchange information with one another, and then automatically update data and status’.

Value-Added Solution for Pharmaceutical Distribution

As you can see, integrating your Pharmaceutical ERP system with the software used by your 3PL partners is a much more efficient way of doing business. And, when you compare the costs and time associated with this, you may be happy to find that there is a clear case for electronically exchanging data. Especially, if you have to do a lot of transactions and a high order volume then it must be a better ERP solution for your Pharmaceutical Distribution business.

For more information and a tailored demonstration contact us at Meta-Pharma.

[guidedpapers]

How is software, technology, and equipment used to secure drug supply from the company?

How is software, technology, and equipment used to secure drug supply from the company?

In your case study paper, you will address the following questions. How is software, technology, and equipment used to secure drug supply from the company? What were the benefits of using the serialization initiative to fulfill state and federal compliance requirements? How will retention of legacy WMS and using the adaptive software tool (STEPlogic) position the company for DSCSA compliancy in…

[thinklio]

How is software, technology, and equipment used to secure drug supply from the company?

How is software, technology, and equipment used to secure drug supply from the company?

In your case study paper, you will address the following questions. How is software, technology, and equipment used to secure drug supply from the company? What were the benefits of using the serialization initiative to fulfill state and federal compliance requirements? How will retention of legacy WMS and using the adaptive software tool (STEPlogic) position the company for DSCSA compliancy in…

[interwork2018-blog]

DRUG SUPPLY CHAIN SECURITY ACT: COMPLIANCE IS NOT AS DIFFICULT AS YOU THINK

DSCSA Compliance, Difficulties, and Solutions

Among a lot of reasons that are presently surfacing around FDA track and trace capability, most primitive ones are misconceptions around the definition of product identification and verification. The other is financial, commercial, and infrastructural gaps between large, small, and mid-size companies.

Verification? Product Identification? Definitions Under DSCSA

There are essential issues in how the modern pharmaceutical industry interprets product identification and verification. It is often misunderstood that verification of product identification means that the manufacturer, repackager, is expected to verify whether they make the product. Or there is an identification on the counterfeit in a particular Pharma supply chain automatically point in time.

As per DSCSA identification and verification definition, the manufacturers and the higher-level partners in a supply chain have been bound to ensure (at any time) that a particular request a product verification helps them verify that the product. It includes an identification number, lot number, and other details that are the same as available on the human-readable label and the one submitted to the USFDA regulators.

Resource & Commercial Gaps Among Companies

The commercial, financial, and business capabilities of a well-established pharmaceutical giant, a mid-scale company, or a freshly approved Pharma company would be different. DSCSA compliance is facing significant hurdles. The large-cap companies are capable of undertaking the serialization process and make the necessary changes in their production facilities. But, they are lacking the right business leadership and the required information for successfully carrying out the compliance process. The mid-scale and small pharmaceutical companies are having significant trouble in building a commercially feasible manufacturing and supply chain model. The focus is on embedding the serialization process via contacted manufacturers or a portion of it that remains in the house.

No Standardization of the Serialization Process

One of the hurdles faced by the DSCSA serialization process is that there is no standardization of the serialization process. New-age startups and well-established companies and their CMOS or CIOs are coming out with consultancy services ‘Serialisation as a Service’ concept consulting the short, less resourceful time to managing to get through these processes. Industry experts and thought leaders have outrightly dishonored the idea of one to one consultancy on a global matter, and it is not advisable.

Benefits of

DSCSA Compliance

and Why Every US Pharma Business Needs It?What Is The Real Solution?

DSCSA Compliance can be best managed with strategized, well-structured intervention of technology product that is capable of foolproof security, safety, and data security compromise concerns. It should be bringing all the primary and secondary stakeholders of a farmer supply chain to a single solution. Standardization of the serialization process and decentralization of information is a must. The centralization of vigilance should tope it and policing efforts. They are more critical for a sustainable, successful stride of DSCSA Compliance with the help of DSCSA Software.

What Makes DSCSA Compliance More Feasible?

There have been various entrant Technology Solutions that are getting on and off the Pharmaceutical Landscape. A completely foolproof, robust Blockchain-Based Serialization Solution, DSCSA Software is all you need. Fortunately, the Blockchain is one Technology that is capable of documenting Transactions on a Decentralized database with 99.99% data immutability at all ends. It is the perfect solution allowing a vast number of private or permissioned vendors to register over a Blockchain Platform voluntarily.

It verifies the profile and makes them a part of a wholly secured, highly transparent Pharma Supply Chain Solution. It is a great Solution that Allows Real-time Transactions and foolproof consensus management across all regulators and the leading supply chain partners. It helps in executing supplies across the pharmaceutical consumer base.

Business Benefits of using a

DSCSA Compliance Software

No FDA penalties

Keeping all Pharmaceutical Supply Chain operations abiding by the Serialization process drastically reduces the chances of ending up FDA sanctions and suspension of Services.

Complete Security

Blockchain day, The Traceability Solutions, and DSCSA Software bring SCM operations a lot closer to the SCM compliance eliminating all possibilities of stolen, counter feet, and low activity Drugs.

Secured Scalability

Expanding wide across more Rx rugs for Manufacturing deep down the consumer base is more affordable and feasible with an end to end Serialization Solution.

Business Beyond Boundaries

The power of Blockchain-Based Private and Formation Registries over the Blockchain Platform to successfully impaneled vendors and officially communicate with other partners in the Supply Chain anywhere across the world.

Bulletproof data security

Blockchain Technology is capable of building a decent life Database with imitable Data records in the form of Smart Contracts. All the product-related information and Realtime Transactions are highly secured.

Reduced Compliance Costs

DSCSA Software Solution is capable of drastically reducing the overall compliance cost, which in turn causes higher profitability in the long run.

Eight Times Better Fault Tolerance

Blockchain-Based DSCSA Software enables suppliers and partners and regulators to identify notice, red flag, quarantine that are passed into the Supply Chain just with the help of a click.

Cost-Effective SCM

The high efficient DSCSA Compliance Software enables companies to focus on cutting costs department wise.

Higher Productivity

The Highly Secured and process includes resource utilization rates and makes the human resource capital way more efficient than ever before.

Conclusion

Forceful intrusions of Technology in Pharmaceutical Traceability and Serialization can make DSCSA Compliance way more comfortable than it looks from the outside. Highly robust, new-age Blockchain-Based DSCSA Software eliminates the hassles of building and managing a Technology Platform. Now you can Setup Serialization Solutions with leading Blockchain Development Companies that are making efforts towards standardizing the process Drug Serialization on a Global Scale.

[infinitrak]

Ensure DSCSA Compliance and Protect Patient Safety with Our Comprehensive Solutions

DSCSA compliance is a crucial aspect of the pharmaceutical industry. The Drug Supply Chain Security Act (DSCSA) was implemented to ensure the safety and security of the drug supply chain, and to protect consumers from counterfeit or adulterated drugs. DSCSA compliance is essential for pharmaceutical companies and distributors to ensure that their products are safe and meet regulatory requirements.

One of the key elements of DSCSA compliance is the use of serialization. Serialization involves the use of unique identification codes on each individual package of a drug product. This allows for the tracking and tracing of the product throughout the supply chain, from the manufacturer to the consumer. This helps to identify any issues with the product, such as counterfeiting or adulteration, and allows for quick and efficient recall of any affected products.

Another important aspect of DSCSA compliance is the use of electronic data sharing. Pharmaceutical companies and distributors are required to share data electronically with other members of the supply chain, including wholesalers, dispensers, and regulatory authorities. This helps to ensure that all parties have access to the most up-to-date and accurate information about the products in the supply chain.

One of the challenges of DSCSA compliance is the need for advanced technology and software. Pharmaceutical companies and distributors need to invest in software systems that can handle the complex data management and tracking requirements of DSCSA compliance. This includes systems for serialization, data sharing, and data analytics.

In conclusion, DSCSA compliance is a crucial aspect of the pharmaceutical industry. It is essential for companies and distributors to ensure that their products are safe and meet regulatory requirements. This includes the use of serialization, electronic data sharing, and advanced technology and software. By investing in these systems and processes, companies can ensure that they are compliant with DSCSA regulations, and that they are providing safe and reliable products to consumers.

More Information about DSCSA Labeling Software Visit our website.

[meta-pharma]

Why Pharmaceutical Manufacturing Businesses need ERP Software?

Efficient business processes, centralized management, quick decision-making, and clear analytics have become essential for any business to grow in the modern-day scenario. Each industry has its own reasons for implementing suitable ERP software. Whereas, ERP for Pharma Industry not only enables the consolidation and integration of pharmaceutical manufacturing processes across multiple units but also helps businesses to keep track of operations across the organization.

MetaPharma, an Advanced Pharmaceutical ERP solution helps businesses in organizing their procurement processes, while reducing production and delivery time. Also, it helps manufacturers to be in compliance with cGMP requirements, in addition to providing a simple and cost-efficient process model. Being an ERP for Pharmaceuticals Industry, it understands formulation management requirements and integrates with your operations to provide real-time information.

Important Features of ERP software for Pharma Industry

Mobile Warehousing Management

DSCSA Track & Trace Compliant

CSOS and ARCOS

Quality Control

Orange Books

Executive Dashboard

Serialization Lot and Serial Number Traceability

Bill of Materials

Benefits of ERP Software in Pharmaceutical Manufacturing

MetaPharma, Pharmaceutical ERP system offers the following benefits:

ERP systems for Pharmaceutical Manufacturing ensure absolute compliance to the stringent regulations

Eliminate risk by delivering safer products of superior quality at the right price and right time

Introduce new products to market faster and cheaper than competitors

Real-time batch monitoring to make accurate business decisions

ERP software for the Pharma Industry help maintain formula secrecy

Respond quickly to customer demands

Smoothen operational process flow and enhance profits

Enhance the quality, consistency, and speed to deliver drugs to market

Control costs through reduced wastage, optimum material utilization, and inventory management

Pharma ERP software offer end-to-end bi-directional traceability, from the raw material to the finished product

This way, ERP software for Pharmaceuticals helps manufacturers streamline their entire operations and take a proactive informed decisions to outlast the competition.

For more information and a tailored demonstration contact us at MetaPharma.

[interwork2018-blog]

WATCH OUT: DRUG SUPPLY CHAIN SECURITY ACT IS HERE FOR FDA DRUG TRACK AND TRACE. HOW TO KEEP UP WITH THE US PHARMACEUTICAL SERIALIZATION AND TRACEABILITY?

US Pharmaceutical Serialization and Traceability

Status in 2019

The drug supply chain security act, as enacted by the US Congress in 2013, is now maturing into its latter half with a critical goal approaching in 2023. Presently, it is looking for transformational DSCSA compliance changes for US drug market wholesalers. USFDA registered wholesalers are looking for serialization, and verification requirements are due on 27 November 2019.

The manufacturers, repackagers are already on a well-directed path for lot-to-package level pharmaceutical serialization and traceability. The upcoming four years will see some significant changes, integration scenarios, and updates of USFDA DSCSA compliance software. It will help build a highly automated, secured, seamless supply chain.

Critical Steps for

Pharmaceutical Serialization and Traceability

to enhance FDA Drug Track and Trace Capability

(read more about guidelines & deadlines)

Manufacturers

Manufacturers will always have a requirement of GTIN, Serial Number, Lot Number, Expiry Date (in a human-readable format), and GST Datamatrix. Traditional pharma businesses can look to sourcing these requirements cost-effectively. Established ones can always look into building a better cost-effective facility with a dedicated in-house facility.

Pharmaceutical serialization and traceability can only be sustainably achieved with a localized copy of the database. It should be maintained at the manufacturer’s office. It should be verifiable with a decentralized database for printing GTIN, serial number, Lot number, expiry date, and GST data matrix. All this information has to be channeled on a large scale for the packaging and labeling of various prescribed drugs.

Repackagers

All repackagers and white label service beneficiaries are required for drugmakers. There should be just not be passed into the market without serialization. Pharmaceutical Serialization and Traceability can die a miserable death if medicines manufactured at other vendors’ facilities do not get serialized. It is crucial before officially making the first move into before the supply chain, followed by regulatory compliance acknowledgment.

There should be a system of checks, balances, and re-verification to ensure FDA Drug Track and Trace. It is highly advisable to keep a frequently updated secondary database for following up. It should be maintaining a consensus between data flow is drug packages transit.

Wholesalers

Wholesalers have a huge responsibility and verification of transit data packages, the receipt, and checking for many levels. A wholesaler should try to build a dedicated in the house IoT-automation based warehousing system, which taps in continuous data streams.

It will be helpful in automated serialization, authentication based on a barcode, and data received from the actual digital supply chain, and further verification while down the lane distribution.

The inclusion of IoT-based, who has a network of devices, will reduce the human intervention and possibilities of errors. Automation is expected to reduce the overall idle time; shelf-life is critical, challenging to handle the ones that increase the cost of logistics and warehousing due to temperature.

Dispensers

Logistic partner screen tries to infiltrate a culture of the tools that are bumper-to-bumper driving trucks reducing Airdrie again fuel consumption to a great extent. It is known for increasing the overall cost-effectiveness by 31%. The last mile deliveries and end-logistics can be delegated with delivery-tracking and management systems.

Complete supply chain

Pharmaceutical serialization and traceability facilitates FDA Drug Track and Trace. It will increase seamless communication facilities. It is going to be a transitional phase in pharmaceutical serialization and traceability. It will help the FDA maintain and enhance FDA track and trace it through a digital system.

Pro tips for all pharma supply chain partners:

Please keep a secondary database

Always maintain them frequently update consignment details

Be an active partner on your supply chain digital platform

Act accordingly and get the knowledge to hold request that all levels

Conclusion

Pharmaceutical serialization and Traceability endeavors with drug supplies and security act are entirely directed for enabling FDA track and trace. It will reduce the counterfeits, stolen, low activity drug introduction into the supply chain. It requires a reliable DSCSA compliance software that brings a single solution for pharma supply chain partners and regulators to a single platform. Upcoming years will seek technology adoption. There will be essential urgency among US pharmaceutical businesses to choose a technology partner for further compliance, integration, and management.